A thrombosed aneurysm may aggravate pre-existing, or cause new, symptoms of mass effect and may require medical therapy.The appropriate anti-platelet and anti-coagulation therapy should be administered in accordance with standard medical practice.Placement of multiple Pipeline™ Flex embolisation devices with Shield Technology™ may increase the risk of ischemic complications.Do not attempt to re-position the Pipeline™ Flex embolisation device with Shield Technology™ after deployment past the resheathing marker.Do not use in patients in whom the angiography demonstrates the anatomy is not appropriate for endovascular treatment, due to conditions such as severe intracranial vessel tortuosity or stenosis.If the catheter cannot be advanced through the Pipeline™ Flex embolisation device with Shield Technology™, carefully remove the delivery wire through the Pipeline™ Flex embolisation device with Shield Technology™ construct.If the delivery wire cannot be retracted into the micro catheter, carefully remove the delivery wire and micro catheter simultaneously.Under fluoroscopy, carefully monitor the tip coil during Pipeline™ Flex embolisation device with Shield Technology™ deployment.The presence of other indwelling endovascular stents may interfere with proper deployment and function of the Pipeline™ Flex embolisation device with Shield Technology™.Advancement of the Pipeline™ Flex embolisation device with Shield Technology™ against resistance may result in damage or patient injury. If high forces or excessive friction is encountered during delivery, discontinue delivery of the device and identify the cause of the resistance, remove device and micro catheter simultaneously.Reprocessing and resterilisation increase the risks of patient infection and may compromise device performance. The Pipeline™ Flex embolisation device with Shield Technology™ is not to be used after the expiration date imprinted on the product label.Carefully inspect the sterile package and the Pipeline™ Flex embolisation device with Shield Technology™ prior to use to verify that neither has been damaged during shipment.The Pipeline™ Flex embolisation device with Shield Technology™ should be used by physicians who have received appropriate training for this device. This device should be used only by physicians trained in percutaneous, intravascular techniques and procedures at medical facilities with the appropriate fluoroscopic equipment.This education session will review common risk factors that may lead to respiratory compromise and will explore potential strategies for reducing adverse events, such as continuous etCO2 monitoring. Please see the Open Payments resources page () for more information.įor any technical questions please send an email to: course will provide education and up to date information on respiratory insufficiency, failure, and arrest as these are leading causes of procedural complications and unplanned admissions, and can create a significant cost burden to the healthcare system. By completing this course, you agree to receiving contact hours and having this transfer of value reported as applicable. HCPs who meet the expanded covered recipient provider types under the federal Open Payments program and receive contact hours are subject to reporting under this national disclosure program. This does NOT apply to EMS professionals. Participants who provide or have a license to provide healthcare in MA or VT will not receive a contact hours certificate. Healthcare Professionals, this course offers contact hours. This course provides one contact hour for nurses (California Board of Nursing), RTs (American Association of Respiratory Care), and CRNAs (American Association of Nurse Anesthetists, B Credit).įor U.S.
0 Comments
Leave a Reply. |